Indo Us Biotech Limited Revises Committee Composition Effective April 21, Directors' Changes Confirmed
Indo Us Biotech Limited has released a clarification regarding the composition of its key Board Committees following appointments and resignations of Directors. The revised committee structures are effective from April 21, 2026, based on approvals made at a prior Board meeting.The company confirmed that the composition of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, which was detailed in the Outcome of the Board Meeting held on July 10, 2026, reflects these changes.
The revised committee compositions are as follows:
Audit Committee
| SR. NO. | Name | Designation |
|---|---|---|
| 1. | Ritaben Nileshbhai Kikani | Chairperson |
| 2. | Shilpa Chetanbhai Thumar | Member |
| 3. | Jagdishkumar Devjibhai Ajudiya | Member |
| 4. | Hemanshi Darsh Soni | Member |
Nomination and Remuneration Committee
| SR. NO. | Name | Designation |
|---|---|---|
| 1. | Shilpa Chetanbhai Thumar | Chairperson |
| 2. | Ritaben Nileshbhai Kikani | Member |
| 3. | Hemanshi Darsh Soni | Member |
Stakeholders Relationship Committee
| SR. NO. | Name | Designation |
|---|---|---|
| 1. | Ritaben Nileshbhai Kikani | Chairperson |
| 2. | Jagdishkumar Devjibhai Ajudiya | Member |
| 3. | Hemanshi Darsh Soni | Member |
| 4. | Shilpa Chetanbhai Thumar | Member |
The company stated that the committee composition detailed in the Outcome of the Board Meeting dated July 10, 2026, is now read as effective from April 21, 2026, corresponding to the effective date of the Directors' appointments and resignations.
Indo Us Biotech Limited confirmed that all other disclosures and contents of the Outcome of the Board Meeting dated July 10, 2026 shall remain unchanged, pending this clarification regarding the effective date of the committee reconstitution.
INDOUS Stock Price Movement
Shares of Indo Us Biotech Limited today slipped by 3.17% to settle at ₹87.04. The equity traded under significant pressure, closing after hitting an intraday low near ₹86.11 on a volume of 30,319 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.